Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Informing efficient pilot development of animal trauma models through quality improvement strategies.

Reynolds PS, McCarter J, Sweeney C, Mohammed BM, Brophy DF, Fisher B, Martin EJ, Natarajan R.

Lab Anim. 2018 Oct 9:23677218802999. doi: 10.1177/0023677218802999. [Epub ahead of print]

PMID:
30296892
2.

Protected land: Many factors shape success.

Gavin MC, McCarter J, Berkes F, Sterling EJ, Turner NJ.

Science. 2018 Aug 10;361(6402):561. doi: 10.1126/science.aau5168. No abstract available.

PMID:
30093591
3.

Drivers of reef shark abundance and biomass in the Solomon Islands.

Goetze JS, Langlois TJ, McCarter J, Simpfendorfer CA, Hughes A, Leve JT, Jupiter SD.

PLoS One. 2018 Jul 30;13(7):e0200960. doi: 10.1371/journal.pone.0200960. eCollection 2018.

4.

Assessing the Effects of Fire Disturbances and Timber Management on Carbon Storage in the Greater Yellowstone Ecosystem.

Zhao F, Healey SP, Huang C, McCarter JB, Garrard C, Goeking SA, Zhu Z.

Environ Manage. 2018 Oct;62(4):766-776. doi: 10.1007/s00267-018-1073-y. Epub 2018 Jun 15.

PMID:
29947968
5.

Birth, evolution, and transmission of satellite-free mammalian centromeric domains.

Nergadze SG, Piras FM, Gamba R, Corbo M, Cerutti F, McCarter JGW, Cappelletti E, Gozzo F, Harman RM, Antczak DF, Miller D, Scharfe M, Pavesi G, Raimondi E, Sullivan KF, Giulotto E.

Genome Res. 2018 Jun;28(6):789-799. doi: 10.1101/gr.231159.117. Epub 2018 Apr 30.

6.

Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.

Bhanpuri NH, Hallberg SJ, Williams PT, McKenzie AL, Ballard KD, Campbell WW, McCarter JP, Phinney SD, Volek JS.

Cardiovasc Diabetol. 2018 May 1;17(1):56. doi: 10.1186/s12933-018-0698-8.

7.

Interventional vitamin C: A strategy for attenuation of coagulopathy and inflammation in a swine multiple injuries model.

Reynolds PS, Fisher BJ, McCarter J, Sweeney C, Martin EJ, Middleton P, Ellenberg M, Fowler E, Brophy DF, Fowler AA 3rd, Spiess BD, Natarajan R.

J Trauma Acute Care Surg. 2018 Jul;85(1S Suppl 2):S57-S67. doi: 10.1097/TA.0000000000001844.

PMID:
29538225
8.

Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study.

Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS.

Diabetes Ther. 2018 Apr;9(2):613-621. doi: 10.1007/s13300-018-0386-4.

9.

Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study.

Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS.

Diabetes Ther. 2018 Apr;9(2):583-612. doi: 10.1007/s13300-018-0373-9. Epub 2018 Feb 7. Erratum in: Diabetes Ther. 2018 Mar 5;:.

10.

Biocultural approaches to well-being and sustainability indicators across scales.

Sterling EJ, Filardi C, Toomey A, Sigouin A, Betley E, Gazit N, Newell J, Albert S, Alvira D, Bergamini N, Blair M, Boseto D, Burrows K, Bynum N, Caillon S, Caselle JE, Claudet J, Cullman G, Dacks R, Eyzaguirre PB, Gray S, Herrera J, Kenilorea P, Kinney K, Kurashima N, Macey S, Malone C, Mauli S, McCarter J, McMillen H, Pascua P, Pikacha P, Porzecanski AL, de Robert P, Salpeteur M, Sirikolo M, Stege MH, Stege K, Ticktin T, Vave R, Wali A, West P, Winter KB, Jupiter SD.

Nat Ecol Evol. 2017 Dec;1(12):1798-1806. doi: 10.1038/s41559-017-0349-6. Epub 2017 Oct 23. Review.

PMID:
29062123
11.

A "Click Chemistry Platform" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation.

Wurz RP, Dellamaggiore K, Dou H, Javier N, Lo MC, McCarter JD, Mohl D, Sastri C, Lipford JR, Cee VJ.

J Med Chem. 2018 Jan 25;61(2):453-461. doi: 10.1021/acs.jmedchem.6b01781. Epub 2017 Apr 17.

PMID:
28378579
12.

A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes.

McKenzie AL, Hallberg SJ, Creighton BC, Volk BM, Link TM, Abner MK, Glon RM, McCarter JP, Volek JS, Phinney SD.

JMIR Diabetes. 2017 Mar 7;2(1):e5. doi: 10.2196/diabetes.6981.

13.

Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin Inhibitors and Cocrystal Structure with GDP-Mannose 4,6-Dehydratase.

Allen JG, Mujacic M, Frohn MJ, Pickrell AJ, Kodama P, Bagal D, San Miguel T, Sickmier EA, Osgood S, Swietlow A, Li V, Jordan JB, Kim KW, Rousseau AC, Kim YJ, Caille S, Achmatowicz M, Thiel O, Fotsch CH, Reddy P, McCarter JD.

ACS Chem Biol. 2016 Oct 21;11(10):2734-2743. Epub 2016 Aug 11.

PMID:
27434622
14.

Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430).

Gonzalez-Lopez de Turiso F, Hao X, Shin Y, Bui M, Campuzano ID, Cardozo M, Dunn MC, Duquette J, Fisher B, Foti RS, Henne K, He X, Hu YL, Kelly RC, Johnson MG, Lucas BS, McCarter J, McGee LR, Medina JC, Metz D, San Miguel T, Mohn D, Tran T, Vissinga C, Wannberg S, Whittington DA, Whoriskey J, Yu G, Zalameda L, Zhang X, Cushing TD.

J Med Chem. 2016 Aug 11;59(15):7252-67. doi: 10.1021/acs.jmedchem.6b00827. Epub 2016 Jul 25.

PMID:
27411843
15.

D-PLACE: A Global Database of Cultural, Linguistic and Environmental Diversity.

Kirby KR, Gray RD, Greenhill SJ, Jordan FM, Gomes-Ng S, Bibiko HJ, Blasi DE, Botero CA, Bowern C, Ember CR, Leehr D, Low BS, McCarter J, Divale W, Gavin MC.

PLoS One. 2016 Jul 8;11(7):e0158391. doi: 10.1371/journal.pone.0158391. eCollection 2016.

16.

Production of Highly Polarized Positrons Using Polarized Electrons at MeV Energies.

Abbott D, Adderley P, Adeyemi A, Aguilera P, Ali M, Areti H, Baylac M, Benesch J, Bosson G, Cade B, Camsonne A, Cardman LS, Clark J, Cole P, Covert S, Cuevas C, Dadoun O, Dale D, Dong H, Dumas J, Fanchini E, Forest T, Forman E, Freyberger A, Froidefond E, Golge S, Grames J, Guèye P, Hansknecht J, Harrell P, Hoskins J, Hyde C, Josey B, Kazimi R, Kim Y, Machie D, Mahoney K, Mammei R, Marton M, McCarter J, McCaughan M, McHugh M, McNulty D, Mesick KE, Michaelides T, Michaels R, Moffit B, Moser D, Muñoz Camacho C, Muraz JF, Opper A, Poelker M, Réal JS, Richardson L, Setiniyaz S, Stutzman M, Suleiman R, Tennant C, Tsai C, Turner D, Ungaro M, Variola A, Voutier E, Wang Y, Zhang Y; PEPPo Collaboration.

Phys Rev Lett. 2016 May 27;116(21):214801. doi: 10.1103/PhysRevLett.116.214801. Epub 2016 May 27.

PMID:
27284661
17.

Rivaroxaban and retropharyngeal haemorrhage.

McCarter JA, Bell PR, McCadden L, Scally C.

BMJ Case Rep. 2016 Feb 16;2016. pii: bcr2015212446. doi: 10.1136/bcr-2015-212446.

18.

High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors: A Complete Workflow.

Campuzano ID, San Miguel T, Rowe T, Onea D, Cee VJ, Arvedson T, McCarter JD.

J Biomol Screen. 2016 Feb;21(2):136-44. doi: 10.1177/1087057115621288. Epub 2015 Dec 16.

PMID:
26676098
19.

Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors.

Shin Y, Suchomel J, Cardozo M, Duquette J, He X, Henne K, Hu YL, Kelly RC, McCarter J, McGee LR, Medina JC, Metz D, San Miguel T, Mohn D, Tran T, Vissinga C, Wong S, Wannberg S, Whittington DA, Whoriskey J, Yu G, Zalameda L, Zhang X, Cushing TD.

J Med Chem. 2016 Jan 14;59(1):431-47. doi: 10.1021/acs.jmedchem.5b01651. Epub 2015 Dec 21.

PMID:
26652588
20.

Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution.

Cee VJ, Volak LP, Chen Y, Bartberger MD, Tegley C, Arvedson T, McCarter J, Tasker AS, Fotsch C.

J Med Chem. 2015 Dec 10;58(23):9171-8. doi: 10.1021/acs.jmedchem.5b01018. Epub 2015 Nov 18.

PMID:
26580091
21.

The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors.

Stec MM, Andrews KL, Bo Y, Caenepeel S, Liao H, McCarter J, Mullady EL, San Miguel T, Subramanian R, Tamayo N, Whittington DA, Wang L, Wu T, Zalameda LP, Zhang N, Hughes PE, Norman MH.

Bioorg Med Chem Lett. 2015 Oct 1;25(19):4136-42. doi: 10.1016/j.bmcl.2015.08.016. Epub 2015 Aug 8.

PMID:
26298499
22.

Development of a nucleotide sugar purification method using a mixed mode column & mass spectrometry detection.

Eastwood H, Xia F, Lo MC, Zhou J, Jordan JB, McCarter J, Barnhart WW, Gahm KH.

J Pharm Biomed Anal. 2015 Nov 10;115:402-9. doi: 10.1016/j.jpba.2015.08.001. Epub 2015 Aug 4.

PMID:
26279371
23.

Inhibition of amyloid-β plaque formation by α-synuclein.

Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Müller A, Prinz M, Steiner H, Hyman BT, Haass C, Meyer-Luehmann M.

Nat Med. 2015 Jul;21(7):802-7. doi: 10.1038/nm.3885. Epub 2015 Jun 22.

PMID:
26099047
24.

Synthesis and SAR study of potent and selective PI3Kδ inhibitors.

Bui M, Hao X, Shin Y, Cardozo M, He X, Henne K, Suchomel J, McCarter J, McGee LR, San Miguel T, Medina JC, Mohn D, Tran T, Wannberg S, Wong J, Wong S, Zalameda L, Metz D, Cushing TD.

Bioorg Med Chem Lett. 2015 Mar 1;25(5):1104-9. doi: 10.1016/j.bmcl.2015.01.001. Epub 2015 Jan 17.

PMID:
25666823
25.

Defining biocultural approaches to conservation.

Gavin MC, McCarter J, Mead A, Berkes F, Stepp JR, Peterson D, Tang R.

Trends Ecol Evol. 2015 Mar;30(3):140-5. doi: 10.1016/j.tree.2014.12.005. Epub 2015 Jan 23.

PMID:
25622889
26.

Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease.

Cushing TD, Hao X, Shin Y, Andrews K, Brown M, Cardozo M, Chen Y, Duquette J, Fisher B, Gonzalez-Lopez de Turiso F, He X, Henne KR, Hu YL, Hungate R, Johnson MG, Kelly RC, Lucas B, McCarter JD, McGee LR, Medina JC, San Miguel T, Mohn D, Pattaropong V, Pettus LH, Reichelt A, Rzasa RM, Seganish J, Tasker AS, Wahl RC, Wannberg S, Whittington DA, Whoriskey J, Yu G, Zalameda L, Zhang D, Metz DP.

J Med Chem. 2015 Jan 8;58(1):480-511. doi: 10.1021/jm501624r. Epub 2014 Dec 3.

PMID:
25469863
27.

Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511.

Lanman BA, Reed AB, Cee VJ, Hong FT, Pettus LH, Wurz RP, Andrews KL, Jiang J, McCarter JD, Mullady EL, San Miguel T, Subramanian R, Wang L, Whittington DA, Wu T, Zalameda L, Zhang N, Tasker AS, Hughes PE, Norman MH.

Bioorg Med Chem Lett. 2014 Dec 15;24(24):5630-5634. doi: 10.1016/j.bmcl.2014.10.085. Epub 2014 Nov 1.

PMID:
25466188
28.

Use of a small molecule cell cycle inhibitor to control cell growth and improve specific productivity and product quality of recombinant proteins in CHO cell cultures.

Du Z, Treiber D, McCarter JD, Fomina-Yadlin D, Saleem RA, McCoy RE, Zhang Y, Tharmalingam T, Leith M, Follstad BD, Dell B, Grisim B, Zupke C, Heath C, Morris AE, Reddy P.

Biotechnol Bioeng. 2015 Jan;112(1):141-55. doi: 10.1002/bit.25332. Epub 2014 Sep 2.

29.

Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.

Chen JJ, Qian W, Biswas K, Yuan C, Amegadzie A, Liu Q, Nixey T, Zhu J, Ncube M, Rzasa RM, Chavez F Jr, Chen N, DeMorin F, Rumfelt S, Tegley CM, Allen JR, Hitchcock S, Hungate R, Bartberger MD, Zalameda L, Liu Y, McCarter JD, Zhang J, Zhu L, Babu-Khan S, Luo Y, Bradley J, Wen PH, Reid DL, Koegler F, Dean C Jr, Hickman D, Correll TL, Williamson T, Wood S.

Bioorg Med Chem Lett. 2013 Dec 1;23(23):6447-54. doi: 10.1016/j.bmcl.2013.09.041. Epub 2013 Sep 29.

PMID:
24139583
30.

Local perceptions of changes in traditional ecological knowledge: a case study from Malekula island, Vanuatu.

McCarter J, Gavin MC.

Ambio. 2014 Apr;43(3):288-96. doi: 10.1007/s13280-013-0431-5. Epub 2013 Aug 9.

31.

Clustering of plaques contributes to plaque growth in a mouse model of Alzheimer's disease.

McCarter JF, Liebscher S, Bachhuber T, Abou-Ajram C, Hübener M, Hyman BT, Haass C, Meyer-Luehmann M.

Acta Neuropathol. 2013 Aug;126(2):179-88. doi: 10.1007/s00401-013-1137-2. Epub 2013 Jun 18.

32.

Assessment of the integrity of compounds stored in assay-ready plates using a kinase sentinel assay.

Chen A, Zhao X, Mercer L, Su C, Zalameda L, Liu Y, Lembke A, Eastwood H, Dang S, Oung T, Xia X, Young SW, Xiao S, McCarter JD.

Comb Chem High Throughput Screen. 2013 Sep;16(8):644-51.

PMID:
23651141
33.

IgG1 thioether bond formation in vivo.

Zhang Q, Schenauer MR, McCarter JD, Flynn GC.

J Biol Chem. 2013 Jun 7;288(23):16371-82. doi: 10.1074/jbc.M113.468397. Epub 2013 Apr 25.

34.

Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511.

Norman MH, Andrews KL, Bo YY, Booker SK, Caenepeel S, Cee VJ, D'Angelo ND, Freeman DJ, Herberich BJ, Hong FT, Jackson CL, Jiang J, Lanman BA, Liu L, McCarter JD, Mullady EL, Nishimura N, Pettus LH, Reed AB, Miguel TS, Smith AL, Stec MM, Tadesse S, Tasker A, Aidasani D, Zhu X, Subramanian R, Tamayo NA, Wang L, Whittington DA, Wu B, Wu T, Wurz RP, Yang K, Zalameda L, Zhang N, Hughes PE.

J Med Chem. 2012 Sep 13;55(17):7796-816. doi: 10.1021/jm300846z. Epub 2012 Aug 30. Erratum in: J Med Chem. 2012 Oct 25;55(20):8975.

PMID:
22897589
35.

Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold.

Wurz RP, Liu L, Yang K, Nishimura N, Bo Y, Pettus LH, Caenepeel S, Freeman DJ, McCarter JD, Mullady EL, Miguel TS, Wang L, Zhang N, Andrews KL, Whittington DA, Jiang J, Subramanian R, Hughes PE, Norman MH.

Bioorg Med Chem Lett. 2012 Sep 1;22(17):5714-20. doi: 10.1016/j.bmcl.2012.06.078. Epub 2012 Jul 3.

PMID:
22832322
36.

Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinases.

Smith AL, D'Angelo ND, Bo YY, Booker SK, Cee VJ, Herberich B, Hong FT, Jackson CL, Lanman BA, Liu L, Nishimura N, Pettus LH, Reed AB, Tadesse S, Tamayo NA, Wurz RP, Yang K, Andrews KL, Whittington DA, McCarter JD, Miguel TS, Zalameda L, Jiang J, Subramanian R, Mullady EL, Caenepeel S, Freeman DJ, Wang L, Zhang N, Wu T, Hughes PE, Norman MH.

J Med Chem. 2012 Jun 14;55(11):5188-219. doi: 10.1021/jm300184s. Epub 2012 May 23.

PMID:
22548365
37.
38.

Thermodynamic evaluation of ligand binding in the plant-like phosphoethanolamine methyltransferases of the parasitic nematode Haemonchus contortus.

Lee SG, Haakenson W, McCarter JP, Williams DJ, Hresko MC, Jez JM.

J Biol Chem. 2011 Nov 4;286(44):38060-8. doi: 10.1074/jbc.M111.290619. Epub 2011 Sep 13.

39.

Structural, mechanistic, and computational analysis of the effects of anomeric fluorines on anomeric fluoride departure in 5-fluoroxylosyl fluorides.

Lee SS, Greig IR, Vocadlo DJ, McCarter JD, Patrick BO, Withers SG.

J Am Chem Soc. 2011 Oct 12;133(40):15826-9. doi: 10.1021/ja204829r. Epub 2011 Sep 19.

PMID:
21910446
40.

Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors.

Meininger D, Zalameda L, Liu Y, Stepan LP, Borges L, McCarter JD, Sutherland CL.

Biochim Biophys Acta. 2011 Dec;1814(12):1947-54. doi: 10.1016/j.bbapap.2011.07.023. Epub 2011 Jul 31.

PMID:
21835273
41.

STK33 kinase activity is nonessential in KRAS-dependent cancer cells.

Babij C, Zhang Y, Kurzeja RJ, Munzli A, Shehabeldin A, Fernando M, Quon K, Kassner PD, Ruefli-Brasse AA, Watson VJ, Fajardo F, Jackson A, Zondlo J, Sun Y, Ellison AR, Plewa CA, San MT, Robinson J, McCarter J, Schwandner R, Judd T, Carnahan J, Dussault I.

Cancer Res. 2011 Sep 1;71(17):5818-26. doi: 10.1158/0008-5472.CAN-11-0778. Epub 2011 Jul 8.

42.

Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability.

Stec MM, Andrews KL, Booker SK, Caenepeel S, Freeman DJ, Jiang J, Liao H, McCarter J, Mullady EL, San Miguel T, Subramanian R, Tamayo N, Wang L, Yang K, Zalameda LP, Zhang N, Hughes PE, Norman MH.

J Med Chem. 2011 Jul 28;54(14):5174-84. doi: 10.1021/jm2004442. Epub 2011 Jun 29.

PMID:
21714526
43.

Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives.

Nishimura N, Siegmund A, Liu L, Yang K, Bryan MC, Andrews KL, Bo Y, Booker SK, Caenepeel S, Freeman D, Liao H, McCarter J, Mullady EL, San Miguel T, Subramanian R, Tamayo N, Wang L, Whittington DA, Zalameda L, Zhang N, Hughes PE, Norman MH.

J Med Chem. 2011 Jul 14;54(13):4735-51. doi: 10.1021/jm200386s. Epub 2011 Jun 20.

PMID:
21612232
44.

The draft genome of the parasitic nematode Trichinella spiralis.

Mitreva M, Jasmer DP, Zarlenga DS, Wang Z, Abubucker S, Martin J, Taylor CM, Yin Y, Fulton L, Minx P, Yang SP, Warren WC, Fulton RS, Bhonagiri V, Zhang X, Hallsworth-Pepin K, Clifton SW, McCarter JP, Appleton J, Mardis ER, Wilson RK.

Nat Genet. 2011 Mar;43(3):228-35. doi: 10.1038/ng.769. Epub 2011 Feb 20.

45.

Discovery and optimization of a series of benzothiazole phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors.

D'Angelo ND, Kim TS, Andrews K, Booker SK, Caenepeel S, Chen K, D'Amico D, Freeman D, Jiang J, Liu L, McCarter JD, San Miguel T, Mullady EL, Schrag M, Subramanian R, Tang J, Wahl RC, Wang L, Whittington DA, Wu T, Xi N, Xu Y, Yakowec P, Yang K, Zalameda LP, Zhang N, Hughes P, Norman MH.

J Med Chem. 2011 Mar 24;54(6):1789-811. doi: 10.1021/jm1014605. Epub 2011 Feb 18.

PMID:
21332118
46.

Editorial [Hot topic: Label-free detection technologies (Guest editor: John D. McCarter)].

McCarter JD.

Comb Chem High Throughput Screen. 2009 Sep;12(8):740. No abstract available.

PMID:
19758118
47.

Rage against the art gene.

McCarter J.

Newsweek. 2009 Apr 6;153(14):48-51. No abstract available.

PMID:
19655515
48.

Inhibitors of the lipid phosphatase SHIP2 discovered by high-throughput affinity selection-mass spectrometry screening of combinatorial libraries.

Annis DA, Cheng CC, Chuang CC, McCarter JD, Nash HM, Nazef N, Rowe T, Kurzeja RJ, Shipps GW Jr.

Comb Chem High Throughput Screen. 2009 Sep;12(8):760-71. Epub 2009 Sep 1.

PMID:
19531013
49.

The genomes of root-knot nematodes.

Bird DM, Williamson VM, Abad P, McCarter J, Danchin EG, Castagnone-Sereno P, Opperman CH.

Annu Rev Phytopathol. 2009;47:333-51. doi: 10.1146/annurev-phyto-080508-081839. Review.

PMID:
19400640
50.

The transcriptomes of the cattle parasitic nematode Ostertagia ostartagi.

Abubucker S, Zarlenga DS, Martin J, Yin Y, Wang Z, McCarter JP, Gasbarree L, Wilson RK, Mitreva M.

Vet Parasitol. 2009 May 26;162(1-2):89-99. doi: 10.1016/j.vetpar.2009.02.023. Epub 2009 Feb 27.

Supplemental Content

Loading ...
Support Center